Biotech Industry, Biotech News, Biotechnology Articles, pharma biotech.#Pharma #biotech


Posted On May 17 2018 by

pharma biotech

Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms.

Pharma biotech

Toxicity knocks Ardelyx s hyperkalemia hopes back to preclinic

Unexpected side effects have spelled the end for Ardelyx’s drug candidate to treat elevated potassium levels in the blood, which was in phase 3 testing.

Pharma biotech

Cytokinetics cans lead drug after phase 3 ALS wipeout

Cytokinetics canned tirasemtiv after it failed to beat placebo against the primary endpoint or any of the secondary goals in an ALS trial.

Pharma biotech

Step Pharma bags cash for CTPS1 autoimmune R D drive

The $17 million financing equips the lean French biotech to prepare its CTPS1 inhibitors for clinical testing in autoimmune disorders.

Pharma biotech

PTK6 blocker could treat or even prevent ER+ breast cancer metastasis

The enzyme PTK6 could be targeted to quell the growth of estrogen receptor-positive breast cancer, a common form of the disease.

Pharma biotech

Amsterdam beats out Milan to host EMA

After tying with Milan in a third round of voting, Amsterdam will be the new home of the European Medicines Agency.

Pharma biotech

LivaNova to offload Cardiac Rhythm unit for $190M

LivaNova will sell its Cardiac Rhythm Management business to its joint venture partner, MicroPort Scientific.

Pharma biotech

DBV climbs as peanut allergy safety data come in clean

Shares in DBV rose on the back of the data, going a little way to erasing the big drop it suffered after missing its primary efficacy endpoint.

Pharma biotech


Last Updated on: May 17th, 2018 at 5:17 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *